192 related articles for article (PubMed ID: 6347939)
1. [Clinical pharmacology of the newer antihypertensive agents].
Rahn KH
Internist (Berl); 1983 Mar; 24(3):128-34. PubMed ID: 6347939
[No Abstract] [Full Text] [Related]
2. [New hypotensive drugs].
Bar-Andziak E; Chlewicka I
Kardiol Pol; 1981; 24(10):723-8. PubMed ID: 7035734
[No Abstract] [Full Text] [Related]
3. [Forum on hypertension. Part 5. New anti-hypertensive agents in the therapy of hypertension].
Holzgreve H
MMW Munch Med Wochenschr; 1981 May; 123(21):suppl 80-6. PubMed ID: 6265766
[No Abstract] [Full Text] [Related]
4. [Recent antihypertensive agents].
Rahn KH
Med Welt; 1982 Aug; 33(31-32):1087-90. PubMed ID: 6752627
[No Abstract] [Full Text] [Related]
5. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
6. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
Schäfer N; Knaup G
Med Welt; 1983 Feb; 34(5):158-61. PubMed ID: 6341756
[No Abstract] [Full Text] [Related]
7. Antihypertensive treatment in mild hypertension, its problems and future trends.
Widimský J
Cor Vasa; 1987; 29(4 Suppl 1):1-10. PubMed ID: 3315445
[No Abstract] [Full Text] [Related]
8. [Clinical use of new antihypertensives].
Song YC
Zhonghua Yi Xue Za Zhi; 1984 Aug; 64(8):503-7. PubMed ID: 6440700
[No Abstract] [Full Text] [Related]
9. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
Viskoper RJ; Laszt A; Paran E; Ben Ari J; Goren Y; Modan M
Neth J Med; 1987 Aug; 31(1-2):58-65. PubMed ID: 3309693
[No Abstract] [Full Text] [Related]
10. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
11. Hypertension--drug management.
Anand MP
J Assoc Physicians India; 1982 Feb; 30(2):101-5. PubMed ID: 6132908
[No Abstract] [Full Text] [Related]
12. [Improvement of the functional capacity of hypertensive patients treated with guanfacine].
Bazika V; Neuzil P; Tiserová J; Hrabovský F
Cas Lek Cesk; 1986 May; 125(21):637-40. PubMed ID: 3518943
[No Abstract] [Full Text] [Related]
13. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
14. Guanfacine (Estulic) in the treatment of hypertension.
Cor Vasa; 1987; 29(4 Suppl 1):1-52. PubMed ID: 3315446
[No Abstract] [Full Text] [Related]
15. A symposium: Guanfacine--a new choice in centrally acting antihypertensive agents. October 5-6, 1984, Scottsdale, Arizona.
Am J Cardiol; 1986 Mar; 57(9):1E-61E. PubMed ID: 3513524
[No Abstract] [Full Text] [Related]
16. [A clinical study of guanfacine in the treatment of arterial hypertension].
Kheder A; Souilem J; Hassine L; Ben Maiz H; Ben Moussa F; Ben Ayed H
Tunis Med; 1987 Nov; 65(11):709-12. PubMed ID: 3332951
[No Abstract] [Full Text] [Related]
17. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
18. Guanfacine for hypertension.
Med Lett Drugs Ther; 1987 May; 29(740):49-50. PubMed ID: 2883560
[No Abstract] [Full Text] [Related]
19. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
20. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
Magometschnigg D; Bonelli J; Hitzenberger G; Kaik G
Arzneimittelforschung; 1980; 30(6):1005-7. PubMed ID: 6998487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
